{
  "schema_version": "2.0",
  "doc_id": "8718d1412b12479293af4793a54dac41d06fdf67f55eac6276259594a243e825",
  "extracted_at": "2026-02-01T08:53:09.867085+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "Neurobiology of addiction"
      },
      "source_chunk_ids": [
        "10f76094d99e435851589332639c372f"
      ]
    },
    {
      "id": "ent_002",
      "type": "Indication",
      "name": "substance use disorders",
      "attributes": {
        "context": "individuals who have substance use disorders"
      },
      "source_chunk_ids": [
        "bc0f72cfaed6c9800a276890b64133f7"
      ]
    },
    {
      "id": "ent_003",
      "type": "Indication",
      "name": "chronic addiction",
      "attributes": {
        "context": "drug intake and chronic addiction"
      },
      "source_chunk_ids": [
        "bc0f72cfaed6c9800a276890b64133f7"
      ]
    },
    {
      "id": "ent_004",
      "type": "Indication",
      "name": "addictions",
      "attributes": {
        "context": "addictions are similar to other chronic relapsing disorders"
      },
      "source_chunk_ids": [
        "bc0f72cfaed6c9800a276890b64133f7"
      ]
    },
    {
      "id": "ent_005",
      "type": "Indication",
      "name": "diabetes",
      "attributes": {
        "context": "such as diabetes, asthma, and hypertension"
      },
      "source_chunk_ids": [
        "bc0f72cfaed6c9800a276890b64133f7"
      ]
    },
    {
      "id": "ent_006",
      "type": "Indication",
      "name": "asthma",
      "attributes": {
        "context": "such as diabetes, asthma, and hypertension"
      },
      "source_chunk_ids": [
        "bc0f72cfaed6c9800a276890b64133f7"
      ]
    },
    {
      "id": "ent_007",
      "type": "Indication",
      "name": "hypertension",
      "attributes": {
        "context": "such as diabetes, asthma, and hypertension"
      },
      "source_chunk_ids": [
        "bc0f72cfaed6c9800a276890b64133f7"
      ]
    },
    {
      "id": "ent_008",
      "type": "Indication",
      "name": "Addiction",
      "attributes": {
        "context": "Addiction can be conceptualised as a three-stage, recurring cycle"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_009",
      "type": "PharmEffect",
      "name": "intoxication",
      "attributes": {
        "context": "binge/intoxication"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_010",
      "type": "PharmEffect",
      "name": "negative affect",
      "attributes": {
        "context": "withdrawal/negative affect"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_011",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "preoccupation/anticipation (craving)"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_012",
      "type": "PharmEffect",
      "name": "neuroplastic changes",
      "attributes": {
        "context": "involves neuroplastic changes in the brain"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_013",
      "type": "Indication",
      "name": "stress",
      "attributes": {
        "context": "brain reward, stress, and executive function systems"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_014",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "neurobiology of addiction"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_015",
      "type": "PharmEffect",
      "name": "impulsivity",
      "attributes": {
        "context": "A definition of impulsivity is"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_016",
      "type": "PharmEffect",
      "name": "compulsivity",
      "attributes": {
        "context": "A definition of compulsivity is the manifestation of"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_017",
      "type": "PharmEffect",
      "name": "pleasure",
      "attributes": {
        "context": "accompanied by feelings of pleasure or gratification"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_018",
      "type": "PharmEffect",
      "name": "gratification",
      "attributes": {
        "context": "feelings of pleasure or gratification"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_019",
      "type": "Indication",
      "name": "obsessive-compulsive disorder",
      "attributes": {
        "context": "disorders such as obsessive-compulsive disorder"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_020",
      "type": "PharmEffect",
      "name": "tension",
      "attributes": {
        "context": "reduce tension or anxiety"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_021",
      "type": "PharmEffect",
      "name": "anxiety",
      "attributes": {
        "context": "reduce tension or anxiety from obsessive thoughts"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_022",
      "type": "PharmEffect",
      "name": "obsessive thoughts",
      "attributes": {
        "context": "anxiety from obsessive thoughts"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_023",
      "type": "PharmEffect",
      "name": "impulsivity",
      "attributes": {
        "context": "move from impulsivity to compulsivity"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_024",
      "type": "PharmEffect",
      "name": "compulsivity",
      "attributes": {
        "context": "move from impulsivity to compulsivity"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_025",
      "type": "PharmEffect",
      "name": "positive reinforcement",
      "attributes": {
        "context": "shifts from positive to negative reinforcement"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_026",
      "type": "PharmEffect",
      "name": "negative reinforcement",
      "attributes": {
        "context": "shifts from positive to negative reinforcement"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_027",
      "type": "PharmEffect",
      "name": "impulsivity",
      "attributes": {
        "context": "impulsivity and compulsivity can coexist"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_028",
      "type": "PharmEffect",
      "name": "compulsivity",
      "attributes": {
        "context": "impulsivity and compulsivity can coexist"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_029",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "stages of the addiction cycle"
      },
      "source_chunk_ids": [
        "00e9e77dc350fa2caaf0fb13c8d339a8"
      ]
    },
    {
      "id": "ent_030",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "neurobiology of addiction"
      },
      "source_chunk_ids": [
        "9435414e08901ff381166960ba4cec71"
      ]
    },
    {
      "id": "ent_031",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "individuals with addiction"
      },
      "source_chunk_ids": [
        "9435414e08901ff381166960ba4cec71"
      ]
    },
    {
      "id": "ent_032",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "animal model of addiction"
      },
      "source_chunk_ids": [
        "9435414e08901ff381166960ba4cec71"
      ]
    },
    {
      "id": "ent_033",
      "type": "Indication",
      "name": "psychopathological condition",
      "attributes": {
        "context": "associated with the psychopathological condition"
      },
      "source_chunk_ids": [
        "9435414e08901ff381166960ba4cec71"
      ]
    },
    {
      "id": "ent_034",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesocorticolimbic dopamine system"
      },
      "source_chunk_ids": [
        "6fb86e275a43eac76b72f0341bc6a37d"
      ]
    },
    {
      "id": "ent_035",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "phasic dopamine cell firing"
      },
      "source_chunk_ids": [
        "2e22989c2a2e2186b1bba7f4975ce5cf"
      ]
    },
    {
      "id": "ent_036",
      "type": "Compound",
      "name": "dopamine D1 receptors",
      "attributes": {
        "context": "activation of dopamine D1 receptors"
      },
      "source_chunk_ids": [
        "2e22989c2a2e2186b1bba7f4975ce5cf"
      ]
    },
    {
      "id": "ent_037",
      "type": "PharmEffect",
      "name": "conditioning",
      "attributes": {
        "context": "necessary for conditioning to occur"
      },
      "source_chunk_ids": [
        "2e22989c2a2e2186b1bba7f4975ce5cf"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "involve glutamate-modulated"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ]
    },
    {
      "id": "ent_039",
      "type": "Compound",
      "name": "N-methyl-D-aspartate",
      "attributes": {
        "context": "N-methyl-D-aspartate (NMDA) receptors"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ]
    },
    {
      "id": "ent_040",
      "type": "Compound",
      "name": "NMDA",
      "attributes": {
        "context": "N-methyl-D-aspartate (NMDA) receptors"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ]
    },
    {
      "id": "ent_041",
      "type": "Compound",
      "name": "\\alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid",
      "attributes": {
        "context": "\\alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "AMPA",
      "attributes": {
        "context": "\\alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ]
    },
    {
      "id": "ent_043",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "progression through the addiction cycle"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_044",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "intense desire for the drug (ie, craving)"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_045",
      "type": "PharmEffect",
      "name": "compulsive use",
      "attributes": {
        "context": "compulsive use when individuals with addiction"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_046",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "drive dopamine signalling"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_047",
      "type": "PharmEffect",
      "name": "pharmacological effects",
      "attributes": {
        "context": "when its pharmacological effects lessen"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_048",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "tonic dopamine cell firing"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_049",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "stable dopamine levels in the dopamine projections"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_050",
      "type": "Compound",
      "name": "D1 receptors",
      "attributes": {
        "context": "lower-affinity D1 receptors"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_051",
      "type": "Compound",
      "name": "cyclic adenosine monophosphate",
      "attributes": {
        "context": "stimulate cyclic adenosine monophosphate (cAMP) signalling"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_052",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "stimulate cyclic adenosine monophosphate (cAMP) signalling"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_053",
      "type": "PharmEffect",
      "name": "drug reward",
      "attributes": {
        "context": "involved in both acute drug reward"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_054",
      "type": "PharmEffect",
      "name": "conditioning",
      "attributes": {
        "context": "acute drug reward and conditioning"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_055",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "spikes in dopamine release"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_056",
      "type": "Compound",
      "name": "D2 receptors",
      "attributes": {
        "context": "D2 receptors, which inhibit cAMP signalling"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_057",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "inhibit cAMP signalling"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_058",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "stimulated by both phasic and tonic dopamine"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_059",
      "type": "PharmEffect",
      "name": "drug reward",
      "attributes": {
        "context": "not deemed necessary for drug reward"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_060",
      "type": "Compound",
      "name": "D3 receptors",
      "attributes": {
        "context": "D3 receptors, which are high-affinity dopamine receptors"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_061",
      "type": "Compound",
      "name": "dopamine receptors",
      "attributes": {
        "context": "high-affinity dopamine receptors"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_062",
      "type": "Compound",
      "name": "D1 receptors",
      "attributes": {
        "context": "co-localise in the nucleus accumbens with D1 receptors"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_063",
      "type": "PharmEffect",
      "name": "drug-seeking behaviour",
      "attributes": {
        "context": "associated with drug-seeking behaviour"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ]
    },
    {
      "id": "ent_064",
      "type": "PharmEffect",
      "name": "withdrawal response",
      "attributes": {
        "context": "produce[s] the withdrawal response"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ]
    },
    {
      "id": "ent_065",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "decreases in dopaminergic and serotonergic transmission"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ]
    },
    {
      "id": "ent_066",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {
        "context": "decreases in dopaminergic and serotonergic transmission"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ]
    },
    {
      "id": "ent_067",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {
        "context": "amphetamine-induced"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ]
    },
    {
      "id": "ent_068",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "methylphenidate-induced"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ]
    },
    {
      "id": "ent_069",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "striatal dopamine responses"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ]
    },
    {
      "id": "ent_070",
      "type": "PharmEffect",
      "name": "rewarding effects",
      "attributes": {
        "context": "lower self-reports of the drug\u2019s rewarding effects"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ]
    },
    {
      "id": "ent_071",
      "type": "Compound",
      "name": "opioid",
      "attributes": {
        "context": "responsivity during opioid withdrawal"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_072",
      "type": "Compound",
      "name": "gamma-aminobutyric acid",
      "attributes": {
        "context": "decreases in GABAergic and increases in NMDA glutamatergic transmission"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "N-methyl-D-aspartate",
      "attributes": {
        "context": "decreases in GABAergic and increases in NMDA glutamatergic transmission"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_074",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "decreases in GABAergic and increases in NMDA glutamatergic transmission"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_075",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "nicotinic receptor function in the nucleus accumbens and ventral tegmental area in nicotine"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_076",
      "type": "Compound",
      "name": "ethanol",
      "attributes": {
        "context": "nicotine, alcohol, and other addictions"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_077",
      "type": "Indication",
      "name": "opioid withdrawal",
      "attributes": {
        "context": "responsivity during opioid withdrawal"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_078",
      "type": "Indication",
      "name": "addictions",
      "attributes": {
        "context": "nicotine, alcohol, and other addictions"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_079",
      "type": "Indication",
      "name": "acute withdrawal",
      "attributes": {
        "context": "clinical syndrome of acute withdrawal"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_080",
      "type": "Indication",
      "name": "protracted abstinence",
      "attributes": {
        "context": "protracted abstinence"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_081",
      "type": "PharmEffect",
      "name": "decreases in GABAergic transmission",
      "attributes": {
        "context": "decreases in GABAergic and increases in NMDA glutamatergic transmission"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_082",
      "type": "PharmEffect",
      "name": "increases in NMDA glutamatergic transmission",
      "attributes": {
        "context": "decreases in GABAergic and increases in NMDA glutamatergic transmission"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_083",
      "type": "PharmEffect",
      "name": "decreases in reward system function",
      "attributes": {
        "context": "Such decreases in reward system function"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_084",
      "type": "PharmEffect",
      "name": "loss of interest in normal, non-drug rewards",
      "attributes": {
        "context": "explain the loss of interest in normal, non-drug rewards"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_085",
      "type": "PharmEffect",
      "name": "narrowing of the behavioural repertoire toward drugs and drug-related stimuli",
      "attributes": {
        "context": "narrowing of the behavioural repertoire toward drugs and drug-related stimuli"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ]
    },
    {
      "id": "ent_086",
      "type": "PharmEffect",
      "name": "positive rewarding effects",
      "attributes": {
        "context": "positive rewarding effects of drugs of abuse"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_087",
      "type": "Compound",
      "name": "Corticotropin-releasing factor (CRF)",
      "attributes": {
        "context": "brain stress system mediated by CRF"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_088",
      "type": "PharmEffect",
      "name": "dysregulated",
      "attributes": {
        "context": "CRF are dysregulated"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_089",
      "type": "Indication",
      "name": "dependence",
      "attributes": {
        "context": "drugs with dependence or abuse potential"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_090",
      "type": "Indication",
      "name": "abuse potential",
      "attributes": {
        "context": "drugs with dependence or abuse potential"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_091",
      "type": "PharmEffect",
      "name": "elevated",
      "attributes": {
        "context": "common response of elevated adrenocorticotropin hormone"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_092",
      "type": "Compound",
      "name": "adrenocorticotropin hormone",
      "attributes": {
        "context": "elevated adrenocorticotropin hormone"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_093",
      "type": "Compound",
      "name": "corticosterone",
      "attributes": {
        "context": "elevated adrenocorticotropin hormone, corticosterone"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_094",
      "type": "PharmEffect",
      "name": "acute withdrawal",
      "attributes": {
        "context": "during acute withdrawal"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_095",
      "type": "PharmEffect",
      "name": "tolerance",
      "attributes": {
        "context": "As tolerance and withdrawal develop"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_096",
      "type": "PharmEffect",
      "name": "withdrawal",
      "attributes": {
        "context": "tolerance and withdrawal develop"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_097",
      "type": "Compound",
      "name": "norepinephrine",
      "attributes": {
        "context": "brain stress systems, such as CRF, norepinephrine"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_098",
      "type": "Compound",
      "name": "dynorphin",
      "attributes": {
        "context": "norepinephrine, and dynorphin"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_099",
      "type": "PharmEffect",
      "name": "negative emotional states",
      "attributes": {
        "context": "development of negative emotional states"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_100",
      "type": "PharmEffect",
      "name": "protracted abstinence",
      "attributes": {
        "context": "in withdrawal and protracted abstinence"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_101",
      "type": "PharmEffect",
      "name": "anti-reward",
      "attributes": {
        "context": "concept of anti-reward was developed"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_102",
      "type": "PharmEffect",
      "name": "limit reward",
      "attributes": {
        "context": "act to limit reward"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_103",
      "type": "Compound",
      "name": "CRF receptor antagonists",
      "attributes": {
        "context": "CRF receptor antagonists block"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_104",
      "type": "PharmEffect",
      "name": "anxiety-like effects",
      "attributes": {
        "context": "anxiety-like, stress-like effects of drug withdrawal"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_105",
      "type": "PharmEffect",
      "name": "stress-like effects",
      "attributes": {
        "context": "stress-like effects of drug withdrawal"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_106",
      "type": "PharmEffect",
      "name": "drug withdrawal",
      "attributes": {
        "context": "effects of drug withdrawal"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_107",
      "type": "PharmEffect",
      "name": "excessive drug taking",
      "attributes": {
        "context": "excessive drug taking during compulsive drug seeking"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_108",
      "type": "PharmEffect",
      "name": "compulsive drug seeking",
      "attributes": {
        "context": "compulsive drug seeking in animals"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_109",
      "type": "Compound",
      "name": "kappa opioid receptor antagonists",
      "attributes": {
        "context": "kappa opioid receptor antagonists, when injected"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_110",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "release of dopamine in the nucleus accumbens"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_111",
      "type": "Compound",
      "name": "kappa opioid receptor",
      "attributes": {
        "context": "dynorphin-kappa opioid receptor system"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_112",
      "type": "PharmEffect",
      "name": "negative emotional state",
      "attributes": {
        "context": "contributes to the negative emotional state"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ]
    },
    {
      "id": "ent_113",
      "type": "Indication",
      "name": "relapse",
      "attributes": {
        "context": "key element of relapse in humans"
      },
      "source_chunk_ids": [
        "7b46deac105ce4cbe1e27f2b852f7863"
      ]
    },
    {
      "id": "ent_114",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "defines addiction as a chronic relapsing disorder"
      },
      "source_chunk_ids": [
        "7b46deac105ce4cbe1e27f2b852f7863"
      ]
    },
    {
      "id": "ent_115",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "linked to the construct of craving"
      },
      "source_chunk_ids": [
        "7b46deac105ce4cbe1e27f2b852f7863"
      ]
    },
    {
      "id": "ent_116",
      "type": "Indication",
      "name": "relapse",
      "attributes": {
        "context": "correlate with relapse"
      },
      "source_chunk_ids": [
        "7b46deac105ce4cbe1e27f2b852f7863"
      ]
    },
    {
      "id": "ent_117",
      "type": "Indication",
      "name": "relapse",
      "attributes": {
        "context": "neurobiological mechanisms of relapse"
      },
      "source_chunk_ids": [
        "7b46deac105ce4cbe1e27f2b852f7863"
      ]
    },
    {
      "id": "ent_118",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {
        "context": "sends glutamatergic projections"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ]
    },
    {
      "id": "ent_119",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesocortical dopamine neurons"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ]
    },
    {
      "id": "ent_120",
      "type": "PharmEffect",
      "name": "excitatory control",
      "attributes": {
        "context": "exerting excitatory control over dopamine cell firing"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ]
    },
    {
      "id": "ent_121",
      "type": "PharmEffect",
      "name": "dopamine cell firing",
      "attributes": {
        "context": "control over dopamine cell firing"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ]
    },
    {
      "id": "ent_122",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine release in the prefrontal cortex"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ]
    },
    {
      "id": "ent_123",
      "type": "PharmEffect",
      "name": "dopamine release",
      "attributes": {
        "context": "dopamine release in the prefrontal cortex"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ]
    },
    {
      "id": "ent_124",
      "type": "PharmEffect",
      "name": "drug-induced reinstatement",
      "attributes": {
        "context": "drug-induced reinstatement is mediated"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_125",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "a glutamatergic projection"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_126",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "modulated by dopamine activity"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_127",
      "type": "Compound",
      "name": "D_1 receptor",
      "attributes": {
        "context": "through D_1 and D_2 receptors"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_128",
      "type": "Compound",
      "name": "D_2 receptor",
      "attributes": {
        "context": "through D_1 and D_2 receptors"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_129",
      "type": "PharmEffect",
      "name": "Cue-induced reinstatement",
      "attributes": {
        "context": "Cue-induced reinstatement also involves"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_130",
      "type": "PharmEffect",
      "name": "stress-induced reinstatement",
      "attributes": {
        "context": "the stress-induced reinstatement of drug-related responding"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_131",
      "type": "Compound",
      "name": "CRF",
      "attributes": {
        "context": "activation of both CRF and norepinephrine"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_132",
      "type": "Compound",
      "name": "norepinephrine",
      "attributes": {
        "context": "activation of both CRF and norepinephrine"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_133",
      "type": "Indication",
      "name": "alcohol dependence",
      "attributes": {
        "context": "alcohol dependence models"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_134",
      "type": "PharmEffect",
      "name": "craving-like responses",
      "attributes": {
        "context": "mediates craving-like responses"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ]
    },
    {
      "id": "ent_135",
      "type": "Compound",
      "name": "\u0394FosB",
      "attributes": {
        "context": "accumulating levels of \u0394FosB"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_136",
      "type": "PharmEffect",
      "name": "rewarding effects",
      "attributes": {
        "context": "sensitivity to the rewarding effects of drugs of abuse"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_137",
      "type": "Compound",
      "name": "drugs of abuse",
      "attributes": {
        "context": "rewarding effects of drugs of abuse"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_138",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "maintain a state of addiction"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_139",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "repeated cocaine exposure"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_140",
      "type": "PharmEffect",
      "name": "histone modifications",
      "attributes": {
        "context": "leads to histone modifications"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_141",
      "type": "PharmEffect",
      "name": "pre-mRNA splicing",
      "attributes": {
        "context": "alter pre-mRNA splicing"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_142",
      "type": "PharmEffect",
      "name": "conditioned place preference",
      "attributes": {
        "context": "cocaine-induced conditioned place preference"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ]
    },
    {
      "id": "ent_143",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "cue-induced cocaine seeking"
      },
      "source_chunk_ids": [
        "035c2766f6375060a630490f5e495c03"
      ]
    },
    {
      "id": "ent_144",
      "type": "PharmEffect",
      "name": "cue-induced cocaine seeking",
      "attributes": {
        "context": "risk of cue-induced cocaine seeking"
      },
      "source_chunk_ids": [
        "035c2766f6375060a630490f5e495c03"
      ]
    },
    {
      "id": "ent_145",
      "type": "PharmEffect",
      "name": "incubation of craving",
      "attributes": {
        "context": "cocaine seeking (incubation of craving)"
      },
      "source_chunk_ids": [
        "035c2766f6375060a630490f5e495c03"
      ]
    },
    {
      "id": "ent_146",
      "type": "PharmEffect",
      "name": "prolonged withdrawal",
      "attributes": {
        "context": "during prolonged withdrawal"
      },
      "source_chunk_ids": [
        "035c2766f6375060a630490f5e495c03"
      ]
    },
    {
      "id": "ent_147",
      "type": "PharmEffect",
      "name": "protracted abstinence",
      "attributes": {
        "context": "withdrawal (protracted abstinence in humans)"
      },
      "source_chunk_ids": [
        "035c2766f6375060a630490f5e495c03"
      ]
    },
    {
      "id": "ent_148",
      "type": "Indication",
      "name": "relapse",
      "attributes": {
        "context": "vulnerability to relapse"
      },
      "source_chunk_ids": [
        "035c2766f6375060a630490f5e495c03"
      ]
    },
    {
      "id": "ent_149",
      "type": "Compound",
      "name": "fatty acid amide hydrolase",
      "attributes": {
        "context": "gene for fatty acid amide hydrolase"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ]
    },
    {
      "id": "ent_150",
      "type": "Compound",
      "name": "fatty acid amide hydrolase",
      "attributes": {
        "context": "reduction of fatty acid amide hydrolase expression"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ]
    },
    {
      "id": "ent_151",
      "type": "PharmEffect",
      "name": "reduction of fatty acid amide hydrolase expression",
      "attributes": {
        "context": "presented a reduction of fatty acid amide hydrolase expression"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ]
    },
    {
      "id": "ent_152",
      "type": "PharmEffect",
      "name": "enhanced fronto-amygdala connectivity",
      "attributes": {
        "context": "selectively enhanced fronto-amygdala connectivity"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ]
    },
    {
      "id": "ent_153",
      "type": "PharmEffect",
      "name": "fear extinction learning",
      "attributes": {
        "context": "enhanced ... fear extinction learning"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ]
    },
    {
      "id": "ent_154",
      "type": "PharmEffect",
      "name": "decreased anxiety-like behaviours",
      "attributes": {
        "context": "decreased anxiety-like behaviours"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ]
    },
    {
      "id": "ent_155",
      "type": "PharmEffect",
      "name": "neuroplasticity",
      "attributes": {
        "context": "target for neuroplasticity"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ]
    },
    {
      "id": "ent_156",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "process of addiction"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_157",
      "type": "Compound",
      "name": "drugs",
      "attributes": {
        "context": "risk for drug use"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_158",
      "type": "Indication",
      "name": "substance use disorder",
      "attributes": {
        "context": "risk of a substance use disorder"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_159",
      "type": "Compound",
      "name": "drugs",
      "attributes": {
        "context": "experiment with legal and illegal drugs"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_160",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "Heavy alcohol use"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_161",
      "type": "Indication",
      "name": "neurobehavioural sequelae",
      "attributes": {
        "context": "range of neurobehavioural sequelae"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_162",
      "type": "Indication",
      "name": "impairments in visuospatial processing",
      "attributes": {
        "context": "impairments in visuospatial processing"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_163",
      "type": "Indication",
      "name": "impairments in attention",
      "attributes": {
        "context": "impairments in visuospatial processing, attention, and memory"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_164",
      "type": "Indication",
      "name": "impairments in memory",
      "attributes": {
        "context": "impairments in visuospatial processing, attention, and memory"
      },
      "source_chunk_ids": [
        "7d6c567cb85e77dd56d34f4c8dee3aaf"
      ]
    },
    {
      "id": "ent_165",
      "type": "Indication",
      "name": "mental disorders",
      "attributes": {
        "context": "manual of mental disorders"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_166",
      "type": "Indication",
      "name": "Addiction",
      "attributes": {
        "context": "Addiction and the brain"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_167",
      "type": "Indication",
      "name": "Drug dependence",
      "attributes": {
        "context": "Drug dependence, a chronic medical illness"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_168",
      "type": "Indication",
      "name": "medical illness",
      "attributes": {
        "context": "a chronic medical illness"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_169",
      "type": "Indication",
      "name": "Drug abuse",
      "attributes": {
        "context": "Drug abuse: hedonic homeostatic dysregulation"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_170",
      "type": "Indication",
      "name": "Drug addiction",
      "attributes": {
        "context": "Drug addiction and its underlying neurobiological basis"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_171",
      "type": "Indication",
      "name": "impulsivity",
      "attributes": {
        "context": "aspects of impulsivity"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_172",
      "type": "Indication",
      "name": "Compulsivity",
      "attributes": {
        "context": "Compulsivity, impulsivity, and the DSM-5 process"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_173",
      "type": "Indication",
      "name": "impulsivity",
      "attributes": {
        "context": "Compulsivity, impulsivity, and the DSM-5 process"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_174",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "Neurocircuitry of addiction"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_175",
      "type": "Indication",
      "name": "drug addiction",
      "attributes": {
        "context": "animal models of drug addiction and alcoholism"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_176",
      "type": "Indication",
      "name": "alcoholism",
      "attributes": {
        "context": "drug addiction and alcoholism"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_177",
      "type": "Indication",
      "name": "psychiatric disorders",
      "attributes": {
        "context": "Animal models of psychiatric disorders"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_178",
      "type": "Indication",
      "name": "Drug addiction",
      "attributes": {
        "context": "Drug addiction, dysregulation of reward"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_179",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "dark side of addiction"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_180",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "prefrontal cortex in addiction"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_181",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "habits and addiction"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_182",
      "type": "Compound",
      "name": "opioid",
      "attributes": {
        "context": "endogenous opioid release"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_183",
      "type": "Compound",
      "name": "Serotonin",
      "attributes": {
        "context": "Serotonin at the nexus of impulsivity"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_184",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "reactivity in cocaine addiction"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_185",
      "type": "Indication",
      "name": "impulsivity",
      "attributes": {
        "context": "nexus of impulsivity and cue reactivity"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_186",
      "type": "Indication",
      "name": "cocaine addiction",
      "attributes": {
        "context": "reactivity in cocaine addiction"
      },
      "source_chunk_ids": [
        "4c6ecb606841d8b82f6ab1d389a917b8"
      ]
    },
    {
      "id": "ent_187",
      "type": "Compound",
      "name": "GABAA receptor drugs",
      "attributes": {
        "context": "GABAA receptor drugs and neuronal plasticity"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_188",
      "type": "PharmEffect",
      "name": "neuronal plasticity",
      "attributes": {
        "context": "GABAA receptor drugs and neuronal plasticity"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_189",
      "type": "PharmEffect",
      "name": "reward",
      "attributes": {
        "context": "plasticity in reward and aversion"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_190",
      "type": "PharmEffect",
      "name": "aversion",
      "attributes": {
        "context": "plasticity in reward and aversion"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_191",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "aspects of nicotine abuse"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_192",
      "type": "Indication",
      "name": "nicotine abuse",
      "attributes": {
        "context": "aspects of nicotine abuse"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_193",
      "type": "Indication",
      "name": "Addiction",
      "attributes": {
        "context": "Addiction as a stress surfeit disorder"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_194",
      "type": "Indication",
      "name": "stress surfeit disorder",
      "attributes": {
        "context": "Addiction as a stress surfeit disorder"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_195",
      "type": "PharmEffect",
      "name": "gene transfer",
      "attributes": {
        "context": "Herpes simplex virus-mediated gene transfer"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_196",
      "type": "Compound",
      "name": "Noradrenaline",
      "attributes": {
        "context": "Noradrenaline in the ventral forebrain"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_197",
      "type": "Indication",
      "name": "opiate withdrawal-induced aversion",
      "attributes": {
        "context": "critical for opiate withdrawal-induced aversion"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_198",
      "type": "PharmEffect",
      "name": "arousal",
      "attributes": {
        "context": "Addiction and arousal"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_199",
      "type": "Compound",
      "name": "hypocretin",
      "attributes": {
        "context": "the hypocretin connection"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_200",
      "type": "Compound",
      "name": "RP 67580",
      "attributes": {
        "context": "RP 67580, a selective antagonist"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_201",
      "type": "Compound",
      "name": "neurokinin-1 receptors",
      "attributes": {
        "context": "antagonist of neurokinin-1 receptors"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_202",
      "type": "Compound",
      "name": "naloxone",
      "attributes": {
        "context": "modifies some of the naloxone-precipitated"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_203",
      "type": "Compound",
      "name": "morphine",
      "attributes": {
        "context": "naloxone-precipitated morphine withdrawal signs"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_204",
      "type": "Indication",
      "name": "morphine withdrawal signs",
      "attributes": {
        "context": "morphine withdrawal signs in rats"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_205",
      "type": "Compound",
      "name": "Amphetamine",
      "attributes": {
        "context": "Amphetamine-induced dopamine release"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_206",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Amphetamine-induced dopamine release"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_207",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "blunted in cocaine dependence"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_208",
      "type": "Indication",
      "name": "cocaine dependence",
      "attributes": {
        "context": "blunted in cocaine dependence"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_209",
      "type": "PharmEffect",
      "name": "self-administer cocaine",
      "attributes": {
        "context": "choice to self-administer cocaine"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_210",
      "type": "PharmEffect",
      "name": "opioid receptor-dependent signaling",
      "attributes": {
        "context": "opioid receptor-dependent signaling and behavior"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_211",
      "type": "PharmEffect",
      "name": "behavior",
      "attributes": {
        "context": "signaling and behavior"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_212",
      "type": "Compound",
      "name": "neuropeptide Y (NPY)",
      "attributes": {
        "context": "Brain neuropeptide Y (NPY) in stress"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_213",
      "type": "Indication",
      "name": "stress",
      "attributes": {
        "context": "Y (NPY) in stress and alcohol dependence"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_214",
      "type": "Indication",
      "name": "alcohol dependence",
      "attributes": {
        "context": "stress and alcohol dependence"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_215",
      "type": "Compound",
      "name": "NOP receptors",
      "attributes": {
        "context": "Activation of brain NOP receptors"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_216",
      "type": "Indication",
      "name": "alcohol withdrawal symptoms",
      "attributes": {
        "context": "attenuates acute and protracted alcohol withdrawal symptoms"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_217",
      "type": "Compound",
      "name": "Endocannabinoid",
      "attributes": {
        "context": "Endocannabinoid-mediated synaptic plasticity"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_218",
      "type": "PharmEffect",
      "name": "synaptic plasticity",
      "attributes": {
        "context": "Endocannabinoid-mediated synaptic plasticity"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_219",
      "type": "Indication",
      "name": "addiction-related behavior",
      "attributes": {
        "context": "plasticity and addiction-related behavior"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_220",
      "type": "Compound",
      "name": "oxytocin",
      "attributes": {
        "context": "Role of oxytocin in the neuroadaptation"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_221",
      "type": "Compound",
      "name": "drugs of abuse",
      "attributes": {
        "context": "neuroadaptation to drugs of abuse"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_222",
      "type": "Indication",
      "name": "drugs of abuse",
      "attributes": {
        "context": "neuroadaptation to drugs of abuse"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_223",
      "type": "Compound",
      "name": "Cocaine",
      "attributes": {
        "context": "Cocaine cue-induced dopamine release"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_224",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Cocaine cue-induced dopamine release"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_225",
      "type": "Indication",
      "name": "cocaine dependent participants",
      "attributes": {
        "context": "study in cocaine dependent participants"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_226",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "The glutamate homeostasis hypothesis"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_227",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "hypothesis of addiction"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_228",
      "type": "Compound",
      "name": "heroin",
      "attributes": {
        "context": "relapse to heroin and cocaine seeking"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_229",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "relapse to heroin and cocaine seeking"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_230",
      "type": "Indication",
      "name": "relapse to heroin and cocaine seeking",
      "attributes": {
        "context": "Neurobiology of relapse to heroin and cocaine seeking"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_231",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "mesocorticolimbic\u2014dopamine in reward"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_232",
      "type": "PharmEffect",
      "name": "reward",
      "attributes": {
        "context": "dopamine in reward and addiction"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_233",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "dopamine in reward and addiction"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_234",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "decreases in dopamine release"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_235",
      "type": "Indication",
      "name": "alcoholics",
      "attributes": {
        "context": "detoxified alcoholics"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_236",
      "type": "Indication",
      "name": "addicted human brain",
      "attributes": {
        "context": "The addicted human brain"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_237",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "self-administration of cocaine"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_238",
      "type": "Compound",
      "name": "dopamine D1 receptor",
      "attributes": {
        "context": "dopamine D1 receptor knock-out mice"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_239",
      "type": "PharmEffect",
      "name": "self-administration of cocaine",
      "attributes": {
        "context": "Lack of self-administration of cocaine"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_240",
      "type": "PharmEffect",
      "name": "NMDAR-dependent burst firing",
      "attributes": {
        "context": "Disruption of NMDAR-dependent burst firing"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_241",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "firing by dopamine neurons"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_242",
      "type": "PharmEffect",
      "name": "phasic dopamine-dependent behavior",
      "attributes": {
        "context": "assessment of phasic dopamine-dependent behavior"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_243",
      "type": "Compound",
      "name": "D2-like dopamine receptor antagonists",
      "attributes": {
        "context": "The affinity of D2-like dopamine receptor antagonists"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_244",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "effect on cocaine self-administration"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_245",
      "type": "PharmEffect",
      "name": "cocaine self-administration",
      "attributes": {
        "context": "effect on cocaine self-administration"
      },
      "source_chunk_ids": [
        "2344a7af08388ec1b1616eb0d56aeb7c"
      ]
    },
    {
      "id": "ent_246",
      "type": "Compound",
      "name": "dopamine D2-like receptors",
      "attributes": {
        "context": "Role of dopamine D2-like receptors"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_247",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "in cocaine self-administration"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_248",
      "type": "Compound",
      "name": "D2 receptor antagonists",
      "attributes": {
        "context": "novel D2 receptor antagonists"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_249",
      "type": "PharmEffect",
      "name": "cocaine self-administration",
      "attributes": {
        "context": "in cocaine self-administration"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_250",
      "type": "Compound",
      "name": "D2R",
      "attributes": {
        "context": "D2R striatopallidal neurons"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_251",
      "type": "PharmEffect",
      "name": "inhibit locomotor and drug reward processes",
      "attributes": {
        "context": "inhibit both locomotor and drug reward processes"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_252",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Illicit dopamine transients"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_253",
      "type": "PharmEffect",
      "name": "actions of abused drugs",
      "attributes": {
        "context": "actions of abused drugs"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_254",
      "type": "PharmEffect",
      "name": "Drug-evoked synaptic plasticity",
      "attributes": {
        "context": "Drug-evoked synaptic plasticity in addiction"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_255",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "synaptic plasticity in addiction"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_256",
      "type": "Compound",
      "name": "VTA DA",
      "attributes": {
        "context": "Co-activation of VTA DA and GABA neurons"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_257",
      "type": "Compound",
      "name": "GABA",
      "attributes": {
        "context": "Co-activation of VTA DA and GABA neurons"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_258",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "mediates nicotine reinforcement"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_259",
      "type": "PharmEffect",
      "name": "nicotine reinforcement",
      "attributes": {
        "context": "mediates nicotine reinforcement"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_260",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "understanding of addiction"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_261",
      "type": "Compound",
      "name": "AMPA receptor",
      "attributes": {
        "context": "AMPA receptor plasticity"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_262",
      "type": "PharmEffect",
      "name": "AMPA receptor plasticity",
      "attributes": {
        "context": "AMPA receptor plasticity in the nucleus accumbens"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_263",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "exposure to cocaine"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_264",
      "type": "Compound",
      "name": "VTA CRF",
      "attributes": {
        "context": "VTA CRF neurons"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_265",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "effects of nicotine withdrawal"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_266",
      "type": "PharmEffect",
      "name": "aversive effects",
      "attributes": {
        "context": "mediate the aversive effects of nicotine withdrawal"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_267",
      "type": "Indication",
      "name": "nicotine withdrawal",
      "attributes": {
        "context": "effects of nicotine withdrawal"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_268",
      "type": "PharmEffect",
      "name": "intake escalation",
      "attributes": {
        "context": "promote intake escalation"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_269",
      "type": "Compound",
      "name": "\u03b15 nicotinic receptor subunit",
      "attributes": {
        "context": "Habenular \u03b15 nicotinic receptor subunit signalling"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_270",
      "type": "Compound",
      "name": "nicotine",
      "attributes": {
        "context": "controls nicotine intake"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_271",
      "type": "PharmEffect",
      "name": "controls nicotine intake",
      "attributes": {
        "context": "signalling controls nicotine intake"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_272",
      "type": "Compound",
      "name": "NPY",
      "attributes": {
        "context": "The NPY system"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_273",
      "type": "Indication",
      "name": "stress",
      "attributes": {
        "context": "NPY system in stress"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_274",
      "type": "Indication",
      "name": "anxiety",
      "attributes": {
        "context": "stress, anxiety and depression"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_275",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "stress, anxiety and depression"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_276",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "during alcohol withdrawal"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_277",
      "type": "Indication",
      "name": "alcohol withdrawal",
      "attributes": {
        "context": "during alcohol withdrawal"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_278",
      "type": "Indication",
      "name": "cognitive impairment",
      "attributes": {
        "context": "predicts cognitive impairment"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_279",
      "type": "PharmEffect",
      "name": "excessive alcohol drinking",
      "attributes": {
        "context": "excessive alcohol drinking"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_280",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "Relapse to cocaine-seeking"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_281",
      "type": "PharmEffect",
      "name": "Relapse to cocaine-seeking",
      "attributes": {
        "context": "Relapse to cocaine-seeking"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_282",
      "type": "Indication",
      "name": "Psychomotor stimulant addiction",
      "attributes": {
        "context": "Psychomotor stimulant addiction"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_283",
      "type": "PharmEffect",
      "name": "drug relapse",
      "attributes": {
        "context": "model of drug relapse"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_284",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "hidden island of addiction"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_285",
      "type": "Compound",
      "name": "psychomotor stimulant drugs",
      "attributes": {
        "context": "effects of psychomotor stimulant drugs"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_286",
      "type": "PharmEffect",
      "name": "reward-enhancing effects",
      "attributes": {
        "context": "reward-enhancing and stereotypical effects"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_287",
      "type": "PharmEffect",
      "name": "stereotypical effects",
      "attributes": {
        "context": "stereotypical effects of psychomotor stimulant drugs"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_288",
      "type": "Compound",
      "name": "Calcium",
      "attributes": {
        "context": "Calcium signalling remodelling"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_289",
      "type": "PharmEffect",
      "name": "Calcium signalling remodelling",
      "attributes": {
        "context": "Calcium signalling remodelling and disease"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_290",
      "type": "Indication",
      "name": "disease",
      "attributes": {
        "context": "remodelling and disease"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_291",
      "type": "PharmEffect",
      "name": "reward",
      "attributes": {
        "context": "prediction and reward"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_292",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "Single cocaine exposure"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_293",
      "type": "PharmEffect",
      "name": "long-term potentiation",
      "attributes": {
        "context": "induces long-term potentiation in dopamine neurons"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_294",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "in dopamine neurons"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_295",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "Cocaine seeking habits"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_296",
      "type": "PharmEffect",
      "name": "Cocaine seeking habits",
      "attributes": {
        "context": "Cocaine seeking habits"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_297",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "dopamine-dependent serial connectivity"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_298",
      "type": "Compound",
      "name": "Dopamine",
      "attributes": {
        "context": "Dopamine operates as a subsecond modulator"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_299",
      "type": "PharmEffect",
      "name": "modulator of food seeking",
      "attributes": {
        "context": "modulator of food seeking"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_300",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Stimulant-induced dopamine increases"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_301",
      "type": "PharmEffect",
      "name": "Stimulant-induced dopamine increases",
      "attributes": {
        "context": "Stimulant-induced dopamine increases"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_302",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "active cocaine abusers"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_303",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "model of dopamine system regulation"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_304",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "understanding alcohol and psychostimulant craving"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_305",
      "type": "Compound",
      "name": "psychostimulant",
      "attributes": {
        "context": "alcohol and psychostimulant craving"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_306",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "psychostimulant craving"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_307",
      "type": "Indication",
      "name": "Addiction",
      "attributes": {
        "context": "craving. Addiction"
      },
      "source_chunk_ids": [
        "7f3cf68c752e078385afee549546b9fd"
      ]
    },
    {
      "id": "ent_308",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "high and craving during cocaine self-administration"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_309",
      "type": "PharmEffect",
      "name": "high",
      "attributes": {
        "context": "Neural correlates of high and craving"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_310",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "Neural correlates of high and craving"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_311",
      "type": "PharmEffect",
      "name": "cocaine self-administration",
      "attributes": {
        "context": "during cocaine self-administration"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_312",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "Activation of orbital and medial prefrontal cortex by methylphenidate"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_313",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "methylphenidate in cocaine-addicted subjects"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_314",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "relevance to addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_315",
      "type": "Indication",
      "name": "cocaine-addicted subjects",
      "attributes": {
        "context": "methylphenidate in cocaine-addicted subjects"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_316",
      "type": "PharmEffect",
      "name": "drug cues",
      "attributes": {
        "context": "Neural reactivity to drug cues"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_317",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "drug cues in addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_318",
      "type": "Compound",
      "name": "Cocaine",
      "attributes": {
        "context": "Cocaine cues and dopamine in dorsal striatum"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_319",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Cocaine cues and dopamine in dorsal striatum"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_320",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "mechanism of craving in cocaine addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_321",
      "type": "Indication",
      "name": "cocaine addiction",
      "attributes": {
        "context": "craving in cocaine addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_322",
      "type": "Compound",
      "name": "Cocaine",
      "attributes": {
        "context": "Cocaine cue-induced dopamine release"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_323",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Cocaine cue-induced dopamine release"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_324",
      "type": "Compound",
      "name": "methylphenidate",
      "attributes": {
        "context": "Association of methylphenidate-induced craving"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_325",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "methylphenidate-induced craving"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_326",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "metabolism in cocaine abusers"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_327",
      "type": "Indication",
      "name": "cocaine abusers",
      "attributes": {
        "context": "metabolism in cocaine abusers"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_328",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "implications in addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_329",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Addiction: beyond dopamine reward circuitry"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_330",
      "type": "Indication",
      "name": "Addiction",
      "attributes": {
        "context": "Addiction: beyond dopamine reward circuitry"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_331",
      "type": "Indication",
      "name": "alcohol relapse",
      "attributes": {
        "context": "time to alcohol relapse"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_332",
      "type": "PharmEffect",
      "name": "cocaine craving",
      "attributes": {
        "context": "cue-induced cocaine craving"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_333",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "cue-induced cocaine craving"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_334",
      "type": "PharmEffect",
      "name": "food-craving",
      "attributes": {
        "context": "food-craving activation during fMRI"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_335",
      "type": "PharmEffect",
      "name": "cigarette cravings",
      "attributes": {
        "context": "abstinence-induced cigarette cravings"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_336",
      "type": "Indication",
      "name": "chronic smokers",
      "attributes": {
        "context": "cigarette cravings in chronic smokers"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_337",
      "type": "Indication",
      "name": "addiction to cigarette smoking",
      "attributes": {
        "context": "disrupts addiction to cigarette smoking"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_338",
      "type": "Indication",
      "name": "cocaine-dependent subjects",
      "attributes": {
        "context": "moral judgment in cocaine-dependent subjects"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_339",
      "type": "Compound",
      "name": "corticotropin-releasing factor 1 and 2 receptors",
      "attributes": {
        "context": "localization of corticotropin-releasing factor 1 and 2 receptors"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_340",
      "type": "PharmEffect",
      "name": "craving",
      "attributes": {
        "context": "cue reactivity and craving"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_341",
      "type": "Indication",
      "name": "problem gamblers",
      "attributes": {
        "context": "abstinent problem gamblers"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_342",
      "type": "Indication",
      "name": "heavy smokers",
      "attributes": {
        "context": "heavy smokers and healthy controls"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_343",
      "type": "PharmEffect",
      "name": "smoking cues",
      "attributes": {
        "context": "Brain reactivity to smoking cues"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_344",
      "type": "PharmEffect",
      "name": "tobacco abstinence",
      "attributes": {
        "context": "maintain tobacco abstinence"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_345",
      "type": "Indication",
      "name": "Addiction",
      "attributes": {
        "context": "Addiction, a disease of compulsion and drive"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_346",
      "type": "Indication",
      "name": "Addiction",
      "attributes": {
        "context": "Overlapping neuronal circuits in addiction and obesity"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_347",
      "type": "Indication",
      "name": "obesity",
      "attributes": {
        "context": "addiction and obesity"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_348",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {
        "context": "Imaging dopamine's role in drug abuse and addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_349",
      "type": "Indication",
      "name": "drug abuse",
      "attributes": {
        "context": "dopamine's role in drug abuse and addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_350",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "drug abuse and addiction"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_351",
      "type": "Compound",
      "name": "dopamine D2 receptor",
      "attributes": {
        "context": "Decreased dopamine D2 receptor availability"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_352",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "frontal metabolism in cocaine abusers"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_353",
      "type": "Indication",
      "name": "cocaine abusers",
      "attributes": {
        "context": "frontal metabolism in cocaine abusers"
      },
      "source_chunk_ids": [
        "ea47a37babe30b8c7f911b045f90af14"
      ]
    },
    {
      "id": "ent_354",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "neurobiological basis of addiction"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ]
    },
    {
      "id": "ent_355",
      "type": "PharmEffect",
      "name": "Action inhibition",
      "attributes": {
        "context": "'Action inhibition Emotion control' is associated with vmPFC"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ]
    },
    {
      "id": "ent_356",
      "type": "PharmEffect",
      "name": "Emotion control",
      "attributes": {
        "context": "'Action inhibition Emotion control' is associated with vmPFC"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ]
    },
    {
      "id": "ent_357",
      "type": "PharmEffect",
      "name": "Affective state",
      "attributes": {
        "context": "resulting 'Affective state', 'Stress', and 'Incentive to action'"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ]
    },
    {
      "id": "ent_358",
      "type": "Indication",
      "name": "Stress",
      "attributes": {
        "context": "resulting 'Affective state', 'Stress', and 'Incentive to action'"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ]
    },
    {
      "id": "ent_359",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "relevant to the addiction process"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ]
    },
    {
      "id": "ent_360",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "relevant to the addiction process"
      },
      "source_chunk_ids": [
        "e60a046523b2c5fffebe05dfa9c6b416"
      ]
    },
    {
      "id": "ent_361",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {
        "context": "Glutamate Ventral tegmental area"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_362",
      "type": "Compound",
      "name": "gamma-aminobutyric acid",
      "attributes": {
        "context": "gamma-aminobutyric acid Dorsal striatum"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_363",
      "type": "Compound",
      "name": "Dopamine",
      "attributes": {
        "context": "Dopamine Dorsal striatum"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_364",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {
        "context": "Glutamate Withdrawal/negative affect"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_365",
      "type": "Compound",
      "name": "Corticotropin-releasing factor",
      "attributes": {
        "context": "Corticotropin-releasing factor Central nucleus of amygdala"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_366",
      "type": "Compound",
      "name": "Corticotropin-releasing factor",
      "attributes": {
        "context": "Corticotropin-releasing factor BNST"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_367",
      "type": "Compound",
      "name": "Norepinephrine",
      "attributes": {
        "context": "Norepinephrine Nucleus accumbens shell"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_368",
      "type": "Compound",
      "name": "Dynorphin",
      "attributes": {
        "context": "Dynorphin Habenula"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_369",
      "type": "Compound",
      "name": "Acetylcholine",
      "attributes": {
        "context": "Acetylcholine Central nucleus of amygdala"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_370",
      "type": "Compound",
      "name": "Neuropeptide Y",
      "attributes": {
        "context": "Neuropeptide Y Central nucleus of amygdala"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_371",
      "type": "Compound",
      "name": "Endocannabinoids",
      "attributes": {
        "context": "Endocannabinoids Preoccupation/anticipation"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_372",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {
        "context": "Glutamate Prefrontal cortex"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_373",
      "type": "Compound",
      "name": "gamma-aminobutyric acid",
      "attributes": {
        "context": "gamma-aminobutyric acid Hippocampus"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_374",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {
        "context": "Glutamate Basolateral amygdala"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_375",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {
        "context": "Glutamate BNST"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_376",
      "type": "Compound",
      "name": "Corticotropin-releasing factor",
      "attributes": {
        "context": "Corticotropin-releasing factor BNST"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_377",
      "type": "Compound",
      "name": "Norepinephrine",
      "attributes": {
        "context": "Norepinephrine Insula"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_378",
      "type": "Compound",
      "name": "Corticotropin-releasing factor",
      "attributes": {
        "context": "Corticotropin-releasing factor"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_379",
      "type": "PharmEffect",
      "name": "Binge/intoxication",
      "attributes": {
        "context": "Neurotransmitter Binge/intoxication Ventral tegmental area"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_380",
      "type": "PharmEffect",
      "name": "Withdrawal/negative affect",
      "attributes": {
        "context": "Glutamate Withdrawal/negative affect Ventral tegmental area"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    },
    {
      "id": "ent_381",
      "type": "PharmEffect",
      "name": "Preoccupation/anticipation",
      "attributes": {
        "context": "Endocannabinoids Preoccupation/anticipation Prefrontal cortex"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:04.029534+00:00",
    "original_file": "entities.json"
  }
}